Zobrazeno 1 - 10
of 12 506
pro vyhledávání: '"Franck, F."'
Autor:
Franck F. Rahaghi, Vivien M. Hsu, Robert J. Kaner, Maureen D. Mayes, Ivan O. Rosas, Rajan Saggar, Virginia D. Steen, Mary E. Strek, Elana J. Bernstein, Nitin Bhatt, Flavia V. Castelino, Lorinda Chung, Robyn T. Domsic, Kevin R. Flaherty, Nishant Gupta, Bashar Kahaleh, Fernando J. Martinez, Lee E. Morrow, Teng Moua, Nina Patel, Oksana A. Shlobin, Brian D. Southern, Elizabeth R. Volkmann, Dinesh Khanna
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-16 (2023)
Abstract Background Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for 20–40% of mortality. Evolution of therapeutic option
Externí odkaz:
https://doaj.org/article/f0f7c08666254d739a6ca421ab557bf3
Autor:
John F. Kingrey, Chad E. Miller, Veronica Franco, Jimmy S. Smith, Ronald Zolty, Ronald J. Oudiz, Jean M. Elwing, Jessica H. Huston, Lana Melendres‐Groves, Ashwin Ravichandran, Vijay Balasubramanian, Benjamin Wu, Stephanie Hwang, Scott Seaman, Meredith Broderick, Franck F. Rahaghi
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Treprostinil is a prostacyclin analogue that targets multiple cellular receptors to treat pulmonary arterial hypertension (PAH). In certain scenarios, patients may require aggressive treprostinil titration. Several studies have demonstrated
Externí odkaz:
https://doaj.org/article/d6713b63cd6d420b8006852a2ff0d1ad
Publikováno v:
In Respiratory Medicine May 2023 211
Autor:
Rahaghi, Franck F., Kolaitis, Nicholas A., Adegunsoye, Ayodeji, de Andrade, Joao A., Flaherty, Kevin R., Lancaster, Lisa H., Lee, Joyce S., Levine, Deborah J., Preston, Ioana R., Safdar, Zeenat, Saggar, Rajan, Sahay, Sandeep, Scholand, Mary Beth, Shlobin, Oksana A., Zisman, David A., Nathan, Steven D.
Publikováno v:
In Chest July 2022 162(1):145-155
Autor:
Rahaghi, Franck F.1 (AUTHOR) RAHAGHF@ccf.org, Hsu, Vivien M.2 (AUTHOR), Kaner, Robert J.3 (AUTHOR), Mayes, Maureen D.4 (AUTHOR), Rosas, Ivan O.5 (AUTHOR), Saggar, Rajan6 (AUTHOR), Steen, Virginia D.7 (AUTHOR), Strek, Mary E.8 (AUTHOR), Bernstein, Elana J.9 (AUTHOR), Bhatt, Nitin10 (AUTHOR), Castelino, Flavia V.11 (AUTHOR), Chung, Lorinda12 (AUTHOR), Domsic, Robyn T.13 (AUTHOR), Flaherty, Kevin R.14 (AUTHOR), Gupta, Nishant15 (AUTHOR), Kahaleh, Bashar16 (AUTHOR), Martinez, Fernando J.3 (AUTHOR), Morrow, Lee E.17 (AUTHOR), Moua, Teng18 (AUTHOR), Patel, Nina9,19 (AUTHOR)
Publikováno v:
Respiratory Research. 9/1/2023, Vol. 24 Issue 1, p1-16. 16p.
Autor:
Huda Asif, Franck F. Rahaghi, Akihiro Ohsumi, Julie Philley, Amir Emtiazjoo, Takashi Hirama, Arthur W. Baker, Chin-Chung Shu, Fernanda Silveira, Vincent Poulin, Pete Rizzuto, Miki Nagao, Pierre-Régis Burgel, Steve Hays, Timothy Aksamit, Takeshi Kawasaki, Charles Dela Cruz, Stefano Aliberti, Takahiro Nakajima, Stephen Ruoss, Theodore K. Marras, Gregory I. Snell, Kevin Winthrop, Mehdi Mirsaeidi
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Rationale Nontuberculous mycobacterial (NTM) diseases are difficult-to-treat infections, especially in lung transplant (LTx) candidates. Currently, there is a paucity of recommendations on the management of NTM infections in LTx, focusing on Mycobact
Externí odkaz:
https://doaj.org/article/4c7d713812a8438997c0717e1067401e
Autor:
Baughman, Robert P., Shlobin, Oksana A., Gupta, Rohit, Engel, Peter J., Stewart, Jeffrey I., Lower, Elyse E., Rahaghi, Franck F., Zeigler, Joyce, Nathan, Steven D.
Publikováno v:
In Chest February 2022 161(2):448-457
Publikováno v:
CHEST; Sep2024, Vol. 166 Issue 3, pe83-e87, 5p
Autor:
Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Dual combination therapy with a phosphodiesterase‐5 inhibitor (PDE5i) and endothelin receptor antagonist is recommended for most patients with intermediate‐risk pulmonary arterial hypertension (PAH). The RESPITE and REPLACE studies sugge
Externí odkaz:
https://doaj.org/article/9f5b66c79cd442eda20ab75c66cf4ff1
Autor:
Franck F. Rahaghi, Zeenat Safdar, Anne Whitney Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand, Adrian Shifren, Steven D. Nathan
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background In patients with idiopathic pulmonary fibrosis (IPF) treated with pirfenidone (Esbriet®, Genentech USA, Inc. South San Francisco, CA.), effectively managing treatment-related adverse events (AEs) may improve adherence. Due to a l
Externí odkaz:
https://doaj.org/article/d0b1eef6d42344f291d481150205b102